+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cell Separation Technology Market Report and Forecast 2023-2031

  • PDF Icon


  • 160 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786924
The global cell separation technologies market size attained a value of USD 10.61 billion in 2022. The market is likely to rise further at a CAGR of 16.50% during the forecast period of 2023-2031, expected to attain a market value of USD 41.88 billion by 2031. The key factor contributing to the market growth include the rising prevalence of chronic and infectious diseases.

Cell Separation Technology Market: Introduction

Cell separation technology is a method used to isolate specific cells or populations of cells from a mixed population. It is a technique that is widely used in the fields of biotechnology and medicine to isolate and study specific cell types, such as stem cells or immune cells.

There are several methods of cell separation technology, including physical, chemical, and biological methods. Physical methods involve the use of physical forces, such as centrifugation or filtration, to separate cells based on their size, density, or other physical characteristics. Chemical methods use specific chemicals or ligands to separate cells based on their surface properties. Biological methods use specific antibodies or other biomolecules to selectively label, and separate cells based on their surface markers.

The uses of cell separation technology are varied and extensive. In basic research, cell separation is used to isolate and study specific cell types to better understand their function and behaviour. In clinical applications, cell separation technology is used to isolate and purify specific cells for transplantation or other therapeutic purposes. For example, stem cells can be isolated and purified using cell separation technology for use in regenerative medicine.

In addition, cell separation technology has important applications in diagnostics, particularly in cancer diagnosis and treatment. Cancer cells can be separated from normal cells using specific biomarkers, allowing for early detection and targeted therapy.

Cell Separation Technology Market Segmentations

Market Breakup by Product Type

  • Instruments
  • Centrifuges
  • Flow Cytometers
  • Filtration Systems
  • Magnetic-activated Cell Separator Systems
  • Others
  • Consumables
  • Reagents
  • Kits
  • Media
  • Sera
  • Beads
  • Disposables
  • Others

Market Breakup by Technology Type

  • Immunomagnetic Cell Separation
  • Fluorescence-activated Cell Sorting
  • Density Gradient Centrifugation
  • Microfluidic Cell Separation
  • Others

Market Breakup by Cell Type

  • Human Cells
  • Animals Cells

Market Breakup by Applications

  • Stem Cell Research
  • Immunology
  • Neuroscience
  • Cancer Research
  • Other

Market Breakup by End User

  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Academic and Research Institutes
  • Others

Cell Separation Technology Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Cell Separation Technology Market Scenario

The cell separation technology market has been driven by several key factors, including the increasing prevalence of chronic and infectious diseases, the growing demand for personalized medicine, and advancements in cell-based therapies.

As the global population continues to age, the prevalence of chronic and infectious diseases is on the rise. This has led to a growing demand for more effective diagnostic tools and therapies, including those based on cell separation technology.

In addition, the trend towards personalized medicine has also driven market growth. With the increasing understanding of the genetic and molecular basis of diseases, there is a growing need for personalized treatments that target specific patient populations. Cell separation technology is a critical tool for isolating and studying specific cell populations, allowing for more targeted and effective therapies.

Advancements in cell-based therapies, such as CAR-T cell therapy, have also contributed to the growth of the cell separation technology market. These therapies require the isolation and purification of specific cell populations, which can be achieved through the use of cell separation technology.

Furthermore, the development of new technologies and products, such as microfluidics and magnetic-activated cell sorting (MACS), has also driven market growth. These new technologies offer improved accuracy and efficiency in cell separation, making the process faster and more reliable.

Overall, the cell separation technology market is expected to continue growing in the foreseeable future, driven by these key factors as well as increasing investment in research and development. The increasing demand for personalized medicine and the growing number of applications for cell separation technology are expected to drive market growth in the coming years.

Key Players in the Global Cell Separation Technology Market

The report gives an in-depth analysis of the key players involved in the cell separation technology market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Terumo Corporation
  • STEMCELL Technologies Inc
  • Miltenyi Biotec
  • Merck KGaA,
  • Akadeum Life Sciences
  • Thermo Fisher Scientific Inc
  • BD
  • Bio-Rad Laboratories
  • Carl Zeiss AG
  • General Electric
  • IBA Lifesciences GmbH
  • Elveflow
  • MPR Associates
  • PerkinElmer Inc

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cell Separation Technology Market Overview
3.1 Global Cell Separation Technology Market Historical Value (2016-2022)
3.2 Global Cell Separation Technology Market Forecast Value (2023-2031)
4 Global Cell Separation Technology Market Landscape
4.1 Global Cell Separation Technology Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cell Separation Technology Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
4.2.4 Analysis by End User
5 Global Cell Separation Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis`
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cell Separation Technology Market Segmentation
6.1 Global Cell Separation Technology Market by Product Type
6.1.1 Market Overview
6.1.2 Instruments Centrifuges Flow Cytometers Filtration Systems Magnetic-activated Cell Separator Systems Others
6.1.3 Consumables Reagents Kits Media Sera Beads Disposables Others
6.2 Global Cell Separation Technology Market by Technology Type
6.2.1 Market Overview
6.2.2 Immunomagnetic Cell Separation
6.2.3 Fluorescence-activated Cell Sorting
6.2.4 Density Gradient Centrifugation
6.2.5 Microfluidic Cell Separation
6.2.6 Others
6.3 Global Cell Separation Technology Market by Cell Type
6.3.1 Market Overview
6.3.2 Human Cells
6.3.3 Animals Cells
6.4 Global Cell Separation Technology Market by Applications
6.4.1 Market Overview
6.4.2 Stem Cell Research
6.4.3 Immunology
6.4.4 Neuroscience
6.4.5 Cancer Research
6.4.6 Other
6.5 Global Cell Separation Technology Market by End User
6.5.1 Market Overview
6.5.2 Biotechnology and Pharmaceutical Companies
6.5.3 Hospitals and Diagnostic Laboratories
6.5.4 Academic and Research Institutes
6.5.5 Others
6.6 Global Cell Separation Technology Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Cell Separation Technology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cell Separation Technology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cell Separation Technology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Cell Separation Technology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cell Separation Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Terumo Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 STEMCELL Technologies Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Miltenyi Biotec
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Merck KGaA,
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Akadeum Life Sciences
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Thermo Fisher Scientific Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 BD
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Bio-Rad Laboratories
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Carl Zeiss AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 General Electric
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 QIAGEN
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 IBA Lifesciences GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Elveflow
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 MPR Associates
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 PerkinElmer Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Cell Separation Technology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Terumo Corporation
  • Stemcell Technologies Inc.
  • Miltenyi Biotec
  • Merck Kgaa,
  • Akadeum Life Sciences
  • Thermo Fisher Scientific Inc.
  • Bd
  • Bio-Rad Laboratories
  • Carl Zeiss AG
  • General Electric
  • Qiagen
  • Iba Lifesciences GmbH
  • Elveflow
  • Mpr Associates
  • Perkinelmer Inc.



Table Information